BINDING MOLECULE AGAINST DLL3 AND USE THEREOF
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 18, 2024
app pub date -
May 6, 2022
filing date -
May 8, 2021
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A binding molecule against DLL3 or an antigen-binding fragment thereof, a derivative containing the binding molecule or the antigen-binding fragment thereof, and a pharmaceutical composition are provided. In addition, the related use of the binding molecule or the antigen-binding fragment thereof in the treatment of cancers and in detection and diagnosis is also provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully